Antiretroviral prophylaxis for community exposure to the human immunodeficiency virus in Switzerland, 1997-2000

Swiss Medical Weekly

Volumn 131, Issue 29-30, 2001, Pages 433-437

  Bernasconi, E ^a   Fost, J ^a   Ledergerber, B ^a   Hirschel, B ^a   Francioli, P ^a   Sudre, P ^a  

^a Ospedale Civico Lugano   (Switzerland)

Author keywords

Antiretroviral drugs; HIV postexposure prophylaxis; Prevention strategy; Surveillance; Toxicity

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; ZIDOVUDINE;

ADULT; ARTICLE; CAREGIVER; COMMUNITY CARE; DIARRHEA; DISEASE TRANSMISSION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEEDLE; NEPHROLITHIASIS; PROPHYLAXIS; RISK BENEFIT ANALYSIS; SEPSIS; SEXUAL BEHAVIOR; SWITZERLAND; TOXIC HEPATITIS; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0035963831     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use
2. Postexposure prophylaxis after nonoccupational HIV exposure
3. Sexual transmission of HIV
4. The care of persons with recent sexual exposure to HIV
5. Vorläufige empfehlungen zur HIV-postexpositionsprophylaxe ausserhalb des medizinalbereichs
6. HIV-exposition im medizinalbereich: Allgemeine massnahmen, chemoprophylaxe und meldung
7. HIV testing, counseling, and prophylaxis after sexual assault
8. Postexposure prophylaxis for human immunodeficiency virus (HIV) infection following sexual assault
9. 1993 Sexually transmitted diseases treatment guidelines
10. Detection of seminal antibodies to human immunodeficiency virus in vaginal secretions after sexual intercourse: Possible means of preventing the risk of human immunodeficiency virus transmission in a rape victim
11. Prophylaxis for occupational exposure to HIV
12. Postexposure prophylaxis with zidovudine suppresses human immunodeficiency virus type 1 infection in SCID-hu mice in a time dependent manner
13. Public health service guidelines for the management of healthcare worker exposures to HIV and recommendations for postexposure prophylaxis
14. Viral load and heterosexual transmission of human immunodeficiency virus type 1
15. Management of possible sexual, injecting-drug-use, or other nonoccupational exposure to HIV, including considerations related to antiretroviral therapy public health service statement
16. Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV
17. The impact of a rapid HIV test to limit unnecessary post exposure prophylaxis following occupational exposures
18. Spare postexposure prophylaxis with immediate HIV testing of the source patient